| 1 |
Gaikwad SS, Pathare SR, More MA, Waykhinde NA, Laddha UD, Salunkhe KS, Kshirsagar SJ, Patil SS, Ramteke KH. Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies. J Control Release 2023;355:292-311. [PMID: 36739908 DOI: 10.1016/j.jconrel.2023.01.083] [Reference Citation Analysis]
|
| 2 |
Rosenwasser Y, Berger I, Loewy ZG. Therapeutic Approaches for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. Pathogens 2022;11. [PMID: 36558847 DOI: 10.3390/pathogens11121513] [Reference Citation Analysis]
|
| 3 |
Uruma Y, Manabe T, Fujikura Y, Iikura M, Hojo M, Kudo K. Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis. PLoS One 2022;17:e0276774. [PMID: 36318528 DOI: 10.1371/journal.pone.0276774] [Reference Citation Analysis]
|
| 4 |
Kaderli ST, Karalezli A, Çitil BE, Saatci AO. Endogenous Fungal Endophthalmitis in a Patient Admitted to Intensive Care and Treated with Systemic Steroid for COVID-19. Turk J Ophthalmol 2022;52:139-41. [PMID: 35481735 DOI: 10.4274/tjo.galenos.2022.04324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Uzan G. Asthma and COVID-19. Recent Advances in Asthma Research and Treatments 2022. [DOI: 10.5772/intechopen.96211] [Reference Citation Analysis]
|
| 6 |
Kosugi EM, Villa JF, Ramos HF, Luz-matsumoto GR, Serrano TLI, Campos CACD, Barreto CC, Lima CM, Fornazieri MA, Piltcher O, Lessa MM, Romano FR. Safety for the Rhinologist in the Age of COVID-19: Mask Use, Nasal Corticosteroids, Saline Irrigation, and Endoscopic Procedures – Literature Review. Int Arch Otorhinolaryngol 2022;26:e137-47. [DOI: 10.1055/s-0041-1740988] [Reference Citation Analysis]
|
| 7 |
Tsevegmid U, Solongo O, Narmandakh J, Undrah A, Oyunchimeg A, Gerelmaa N, Nasantogtoh E. Bronchial asthma in children of Mongolia: prevalence and risk factors. RPJ 2022;24:405-413. [DOI: 10.46563/1560-9561-2021-24-6-405-413] [Reference Citation Analysis]
|
| 8 |
Saminan S, Julisafrida L, Ridwan M, Fajri N. COVID-19 Pandemic: What Considerations Should Be Taken during the Assessment and Management of COPD Exacerbation? Open Access Maced J Med Sci 2022;10:71-80. [DOI: 10.3889/oamjms.2022.7930] [Reference Citation Analysis]
|
| 9 |
Hong SM, Park YW, Choi EJ. Steroid injections in pain management: influence on coronavirus disease 2019 vaccines. Korean J Pain 2022;35:14-21. [PMID: 34966008 DOI: 10.3344/kjp.2022.35.1.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Arain S, Thorakkattil S, Krishnan G, Karattuthodi M, Ageeli MA, Chandran S, Abdulsalim S. The necessity of implementing steroid stewardship: Are we lagging behind antimicrobials and opioids? Saudi J Clin Pharm 2022;1:107. [DOI: 10.4103/sjcp.sjcp_16_22] [Reference Citation Analysis]
|
| 11 |
Abdullaev MA, Grechukhin AI, Orlova EA, Kantemirova BI. Pharmacoeconomic Analysis of Inhalation Drugs Availability Used in COPD Treatment. jour 2021;3. [DOI: 10.36107/hfb.2021.i4.s112] [Reference Citation Analysis]
|
| 12 |
Workman AD, Bhattacharyya N. Do Patients With Chronic Rhinosinusitis Exhibit Elevated Rates of Covid-19 Infection? Laryngoscope 2021. [PMID: 34806184 DOI: 10.1002/lary.29961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Gao YD, Agache I, Akdis M, Nadeau K, Klimek L, Jutel M, Akdis CA. The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19. Int Immunol 2021:dxab107. [PMID: 34788827 DOI: 10.1093/intimm/dxab107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Furci F, Caminati M, Senna G, Gangemi S. The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19. Clin Mol Allergy 2021;19:19. [PMID: 34719394 DOI: 10.1186/s12948-021-00159-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
Thambiraja TS, Karuppanan K, Subramaniam G, Kumar S. Identification of COVID-19 and COPD common key genes and pathways using a protein-protein interaction approach.. [DOI: 10.1101/2021.10.28.466298] [Reference Citation Analysis]
|
| 16 |
Essa RA, Ahmed SK, Bapir DH, Rasul SA, Khdir AA, Abubakr CP. Challenge of surviving COPD with COVID-19 patient: review of the literature with unusual case report. International Journal of Surgery: Global Health 2021;4:e65-e65. [DOI: 10.1097/gh9.0000000000000065] [Reference Citation Analysis]
|
| 17 |
Shen K, Hong J, El Beleidy A, Furman E, Liu H, Yin Y, Cano-Salas MDC, AlJassim FM, Al-Shammari N, Lochindarat S, Dieu Thuy NT. International expert opinion on the use of nebulization for pediatric asthma therapy during the COVID-19 pandemic. J Thorac Dis 2021;13:3934-47. [PMID: 34422324 DOI: 10.21037/jtd-21-841] [Reference Citation Analysis]
|
| 18 |
Vivek V, Karuna V, Singh R, Gupta P, Verma N, Rathi M. Co-morbidities: Prevalence and evaluation of risk with COVID-19 (SARS CoV2) infection: A retrospective study. JDPO 2021;6:119-126. [DOI: 10.18231/j.jdpo.2021.026] [Reference Citation Analysis]
|
| 19 |
Vianello A, Del Turco S, Babboni S, Silvestrini B, Ragusa R, Caselli C, Melani L, Fanucci L, Basta G. The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity? Biomedicines 2021;9:710. [PMID: 34201505 DOI: 10.3390/biomedicines9070710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Yong SJ. Diseased lungs may hinder COVID-19 development: A possible reason for the low prevalence of COPD in COVID-19 patients. Med Hypotheses 2021;153:110628. [PMID: 34139599 DOI: 10.1016/j.mehy.2021.110628] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 21 |
Miller LE, Bhattacharyya N. Risk of COVID-19 Infection Among Chronic Rhinosinusitis Patients Receiving Oral Corticosteroids. Otolaryngol Head Neck Surg 2021;:1945998211006931. [PMID: 33845681 DOI: 10.1177/01945998211006931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 22 |
Subramaniam A, Ghazal A. IS ASTHMA AND USE OF INHALED CORTICOSTEROIDS A RISK FACTOR FOR COVID-19 INFECTION?A CLINICAL REVIEW. IJAR 2021. [DOI: 10.36106/1818181] [Reference Citation Analysis]
|
| 23 |
Marques CDL, Kakehasi AM, Pinheiro MM, Mota LMH, Albuquerque CP, Silva CR, Santos GPJ, Reis-Neto ET, Matos P, Devide G, Dantas A, Giorgi RD, Marinho AO, Valadares LDA, Melo AKG, Ribeiro FM, Ferreira GA, Santos FPS, Ribeiro SLE, Andrade NPB, Yazbek MA, Souza VA, Paiva ES, Azevedo VF, Freitas ABSB, Provenza JR, Toledo RA, Fontenelle S, Carneiro S, Xavier R, Pileggi GCS, Reis APMG. High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry. RMD Open 2021;7:e001461. [PMID: 33510041 DOI: 10.1136/rmdopen-2020-001461] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 24 |
Boechat JL, Wandalsen GF, Kuschnir FC, Delgado L. COVID-19 and Pediatric Asthma: Clinical and Management Challenges. Int J Environ Res Public Health 2021;18:1093. [PMID: 33530624 DOI: 10.3390/ijerph18031093] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 25 |
Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol 2021;87:104647. [PMID: 33264669 DOI: 10.1016/j.meegid.2020.104647] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
|
